2.32
price down icon2.11%   -0.05
after-market 시간 외 거래: 2.31 -0.010 -0.43%
loading
전일 마감가:
$2.37
열려 있는:
$2.36
하루 거래량:
531.02K
Relative Volume:
0.13
시가총액:
$129.71M
수익:
$76.19M
순이익/손실:
$-1.61M
주가수익비율:
232.00
EPS:
0.01
순현금흐름:
$28.98M
1주 성능:
-12.12%
1개월 성능:
-23.18%
6개월 성능:
+159.04%
1년 성능:
+65.71%
1일 변동 폭
Value
$2.30
$2.4074
1주일 범위
Value
$2.30
$2.63
52주 변동 폭
Value
$0.5052
$3.22

Spero Therapeutics Inc Stock (SPRO) Company Profile

Name
명칭
Spero Therapeutics Inc
Name
전화
857-242-1600
Name
주소
675 MASSACHUSETTS AVENUE, CAMBRIDGE, MA
Name
직원
32
Name
트위터
@spero_tx
Name
다음 수익 날짜
2025-03-19
Name
최신 SEC 제출 서류
Name
SPRO's Discussions on Twitter

SPRO을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
SPRO
Spero Therapeutics Inc
2.32 147.60M 76.19M -1.61M 28.98M 0.01
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
458.49 121.30B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
545.53 61.60B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.52 41.17B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
566.14 34.35B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.93 27.29B 3.81B -644.79M -669.77M -6.24

Spero Therapeutics Inc Stock (SPRO) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-12-20 다운그레이드 Evercore ISI Outperform → In-line
2022-09-23 업그레이드 Evercore ISI In-line → Outperform
2021-10-01 다운그레이드 Oppenheimer Outperform → Perform
2021-01-22 재확인 H.C. Wainwright Buy
2020-12-16 개시 Berenberg Buy
2020-09-29 개시 Evercore ISI Outperform
2019-11-05 재확인 H.C. Wainwright Buy
2019-09-09 개시 Janney Buy
2018-02-09 개시 Cantor Fitzgerald Overweight
2017-11-27 개시 BofA/Merrill Neutral
2017-11-27 개시 Oppenheimer Outperform
2017-11-27 개시 Stifel Buy
모두보기

Spero Therapeutics Inc 주식(SPRO)의 최신 뉴스

pulisher
Jul 20, 2025

Is Spero Therapeutics Inc. a good long term investmentAccelerated wealth building - Autocar Professional

Jul 20, 2025
pulisher
Jul 19, 2025

What analysts say about Spero Therapeutics Inc. stockUnstoppable investment returns - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

Spero Therapeutics Inc. Stock Analysis and ForecastPowerful growth strategies - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

What drives Spero Therapeutics Inc. stock priceFree Risk Assessment Services - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

Will Spero Therapeutics Inc. stock benefit from AI tech trendsTrend Based Entry Alerts - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

When is the best time to buy Spero Therapeutics Inc. stockFree Real-Time Trading Opportunities - Newser

Jul 18, 2025
pulisher
Jul 16, 2025

Insufficient Growth At Spero Therapeutics, Inc. (NASDAQ:SPRO) Hampers Share Price - simplywall.st

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Spero Therapeutics Inc. stock price move sharplyMarket Timing Advice - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Spero Therapeutics Inc. stock attracts strong analyst attentionTop Momentum Stock Pick - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Spero Therapeutics Inc. stock performs during market volatilityBreakout Level Watch - Newser

Jul 15, 2025
pulisher
Jul 01, 2025

Spero Therapeutics (NASDAQ:SPRO) Stock Passes Above Fifty Day Moving Average – What’s Next? - Defense World

Jul 01, 2025
pulisher
Jun 28, 2025

While institutions own 20% of Spero Therapeutics, Inc. (NASDAQ:SPRO), retail investors are its largest shareholders with 54% ownership - Yahoo

Jun 28, 2025
pulisher
Jun 17, 2025

Complicated Urinary Tract Infection Pipeline Appears Robust With 12+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - The Globe and Mail

Jun 17, 2025
pulisher
Jun 12, 2025

SPRO’s Stock Market Pendulum: Swinging Between Gains and Losses - investchronicle.com

Jun 12, 2025
pulisher
Jun 11, 2025

Spero TherapeuticsAdditional Upside Potential Following Positive Phase 3 Results (SPRO) - Seeking Alpha

Jun 11, 2025
pulisher
Jun 11, 2025

Squarepoint Ops LLC Buys Shares of 55,051 Spero Therapeutics, Inc. (NASDAQ:SPRO) - Defense World

Jun 11, 2025
pulisher
Jun 09, 2025

Spero Therapeutics COO Timothy Keutzer sells shares for $44,097 - MSN

Jun 09, 2025
pulisher
Jun 09, 2025

Jane Street Group LLC Takes Position in Spero Therapeutics, Inc. (NASDAQ:SPRO) - Defense World

Jun 09, 2025
pulisher
Jun 06, 2025

Spero Therapeutics Inc (SPRO) Is A Good Stock To Invest In - Stocksregister

Jun 06, 2025
pulisher
Jun 06, 2025

Spero Therapeutics, Inc. (NASDAQ:SPRO) Stake Boosted by Mackenzie Financial Corp - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

GSK, Spero Therapeutics Stop Antibiotic Trial For Complicated Urinary Tract Infections Early After Positive Results, Retail’s Thrilled - MSN

Jun 06, 2025
pulisher
Jun 04, 2025

Northern Trust Corp Sells 25,050 Shares of Spero Therapeutics, Inc. (NASDAQ:SPRO) - Defense World

Jun 04, 2025
pulisher
May 31, 2025

Why Spero Therapeutics, Inc. (SPRO) Surged Last Week - Insider Monkey

May 31, 2025
pulisher
May 31, 2025

Spero Therapeutics stock hits 52-week high at $2.53 By Investing.com - Investing.com South Africa

May 31, 2025
pulisher
May 31, 2025

Complicated Urinary Tract Infection Oral Antibiotic Approaches Approval - Vax-Before-Travel

May 31, 2025
pulisher
May 30, 2025

Spero Therapeutics stock hits 52-week high at $2.53 - Investing.com India

May 30, 2025
pulisher
May 30, 2025

Spero Therapeutics Jumps as Oral Carbapenem Hits Phase 3 Milestone - MSN

May 30, 2025
pulisher
May 30, 2025

SPRO Stock Soars 245% on GSK-Partnered UTI Drug Meeting Study Goal - MSN

May 30, 2025
pulisher
May 29, 2025

Spero Therapeutics Stock (SPRO) Rockets 225% on Clinical Trial Data - The Globe and Mail

May 29, 2025
pulisher
May 29, 2025

Spero Therapeutics And 2 Other Promising Penny Stocks To Watch - Yahoo Finance

May 29, 2025
pulisher
May 29, 2025

Spero Therapeutics rockets on positive Phase III study for tebipenem HBr - The Pharma Letter

May 29, 2025
pulisher
May 29, 2025

Spero Therapeutics Sees Turbulent Stock Movement Post-Recent Announcements - timothysykes.com

May 29, 2025
pulisher
May 28, 2025

Biotech Finds Mid-Week Success After Meeting Primary Endpoint - The Globe and Mail

May 28, 2025
pulisher
May 28, 2025

GSK’s Bet On Spero’s Oral cUTI Antibiotic Poised To Pay Off With New Phase III Data - insights.citeline.com

May 28, 2025
pulisher
May 28, 2025

Spero Therapeutics Stock Skyrockets on Strong Phase 3 Trial Results - MSN

May 28, 2025
pulisher
May 28, 2025

Spero Therapeutics (SPRO) Stock Explodes: Shares Skyrocket Over 200% in Stunning Midday Rally! - Daily Chhattisgarh News

May 28, 2025
pulisher
May 28, 2025

Why Is GSK Partner Spero Therapeutics Stock Skyrocketing On Wednesday? - Benzinga

May 28, 2025

Spero Therapeutics Inc (SPRO) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$21.69
price down icon 0.87%
$35.65
price up icon 0.17%
$102.78
price up icon 0.22%
$26.34
price up icon 0.53%
$108.91
price down icon 1.01%
biotechnology ONC
$291.93
price down icon 0.89%
자본화:     |  볼륨(24시간):